Skip to main content
Log in

Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats

Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The chemotherapeutic activity of five cytostatic drugs was investigated experimentally in monotherapy and in two-drug combinations, using Yoshida sarcoma cells implanted into the wall of the glandular stomach of Sprague-Dawley rats. In monotherapy, the antibiotic agent mitomycin C and the nitrosourea methyl-CCNU exhibited the highest cytotoxic activity in this tumor model. In combination therapy, the combination of these two drugs was superior to all the other therapeutic schemes tested. In general, the results demonstrate a marked superiority of combination therapy in comparison with monotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ansfield FJ, Schroeder JM, Curreri AR (1962) Five years clinical experience with 5-fluorouracil. JAMA 181:295–299

    Google Scholar 

  • Bhide S, Habs M, Reinbold H Schmähl D (1979) Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats. Arzneim Forsch 29:477–479

    Google Scholar 

  • Carter SK, Comis RL (1977) Gastric cancer: current status of treatment. J Natl Cancer Inst 58:567–568

    Google Scholar 

  • Comis RL, Carter SK (1974) A review of chemotherapy in gastric cancer. Cancer 34:1576–1586

    Google Scholar 

  • Douglass HD, Lavin PT, Moertel CG (1976) Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Cancer Treat Rep 60:769–780

    Google Scholar 

  • Friedman MA, Kimura K, Sakurai Y, Ogawa M, Carter, SK (1980) (for the Northern California Oncology Group) Chemotherapy of advanced gastric cancer. Proc. ASCO 21:418

    Google Scholar 

  • Habs M (1981) Methoden, Ergebnisse und Probleme der experimentellen Chemotherapie. In: Schmähl D (Hrsg) Maligne Tumoran-Entstehung, Wachstum, Chemotherapie. Editio Cantor, Aulendorf, S 455–498

    Google Scholar 

  • Habs M, Reinbold H, Eisenbrand G, Bhide S, Goga-Ionesco S, Schmähl D (1981) Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats. J Cancer Res Clin Oncol 101:285–302

    Google Scholar 

  • Kisner DL, MacDonald JS (1982) Chemotherapy of metastatic gastrointestinal cancers: prospects for future adjuvant systemic therapies. Res Results Cancer Res 80:291–295

    Google Scholar 

  • MacDonald JS, Schein P, Ueno W, Woolley PV (1979) 5-Fluorouracil, mitomycin C and adriamycin (FAM): A new combination chemotherapy program for advanced gastric carcinoma. Cancer 44:42–47

    Google Scholar 

  • Mantel N (1958) An experimental design in combination chemotherapy. Ann NY Acad Sci 76:909–914

    Google Scholar 

  • Moertel CG, Mittelman JA, Bakemeier RF, Engstrom P, Hanley J (1976) Sequential and combination chemotherapy of advanced gastric cancer. Cancer 38:678–682

    Google Scholar 

  • Moertel CG, O'Connell MJ, Lavin PT (1979) Chemotherapy of gastric carcinoma. Proc AACR 20:288

    Google Scholar 

  • O'Connell M, O'Fallon J, Lavin P, Moertel C, Bruckner H, Douglass H Jr, Livestone E, Lokich J, Mitchell M (1980) A comparative assessment of combination chemotherapy in advanced gastric carcinoma. Proc ASCO 21:420

    Google Scholar 

  • Panettiere F, Heibrun L (1979) Comparison of two different combinations of adriamycin, mitomycin-C and 5-FU in the management of gastric carcinoma: A SWOG study. Proc AACR 20:315

    Google Scholar 

  • Peto R (1974) Guidelines on the analysis of tumor rates and death rates in experimental animals. Br J Cancer 29:101–105

    Google Scholar 

  • Peto R, Pike, MC, Day NE, Gray RG, Lee PN, Parish S, Peto J, Richards S, Wahrendorf J (1980) Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In: AIRC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Suppl 2: Long-term and short-term screening assays for carcinogens, a critical appraisal. IARC, Lyon, pp 311–426

    Google Scholar 

  • Schmähl D, Mecke R (1955) Quantitative Transplantationsversuche mit dem Yoshida-Ascitessarkom der Ratte. Z Krebsforsch 60:711–729

    Google Scholar 

  • Schmähl D, Osswald H, Prochotta L (1967) Quantitative Untersuchungen an Ratten über die Resistenz verschiedener Organe gegen inoculierte Tumorzellen. Z Krebsforsch 70:130–137

    Google Scholar 

  • Yoshida T (1949) The Yoshida sarcoma, an ascites tumor. Gann 40:1–18

    Google Scholar 

  • Yoshida T (1952) Studies on an ascites (reticuloendothelial cell?) sarcoma of the rat. J Natl Cancer Inst 12:947–962

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

These studies correspond to the doctoral thesis “Chemotherapeutische Studien an Ratten mit in den Drüsenmagen implantierten Yoshida-Sarkom-Asciteszellen: Monotherapie mit 5-Fluorouracil, Methyl-CCNU, Mitomycin C, Adriamycin und Cytosinarabinosid, Kombinationstherapie mit den Zweierkombinationen dieser Substanzen” submitted to the Medical Faculty of Heidelberg University in 1982 by G. Eichler

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eichler, G., Habs, M. & Schmähl, D. Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. J Cancer Res Clin Oncol 105, 250–257 (1983). https://doi.org/10.1007/BF00395753

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00395753

Key words

Navigation